AAAAAA

   
Results: 1-19 |
Results: 19
Lymphocutaneous syndrome due to Scedosporium apiospermum
Authors: Canet, JJ Pagerols, X Sanchez, C Vives, P Garau, J
Citation: Jj. Canet et al., Lymphocutaneous syndrome due to Scedosporium apiospermum, CL MICRO IN, 7(11), 2001, pp. 648-650
Maximizing Antimicrobial Efficacy/Minimizing Antimicrobial Resistance: A Paradigm for the New Millennium - Proceedings of a Symposium held at the American Academy of Arts and Sciences, Cambridge, Massachusetts, 7-8 December 1999 - General discussion
Authors: Zinner, SH Wise, R Moellering, RC Acar, J Craig, W Davey, P Garau, J Klugman, K Kristinsson, K Levin, B Low, D MacGowan, A O'Brien, T Osterholm, M Pechere, JC Phillips, I Tenover, F Williams, R Young, L
Citation: Sh. Zinner et al., Maximizing Antimicrobial Efficacy/Minimizing Antimicrobial Resistance: A Paradigm for the New Millennium - Proceedings of a Symposium held at the American Academy of Arts and Sciences, Cambridge, Massachusetts, 7-8 December 1999 - General discussion, CLIN INF D, 33, 2001, pp. S251-S260
Clinical failures: the tip of the iceberg?
Authors: Garau, J
Citation: J. Garau, Clinical failures: the tip of the iceberg?, RESP MED, 95, 2001, pp. S7-S13
Steering an appropriate course: principles to guide antibiotic choice - Discussion
Authors: Craig, W Cars, O Garau, J
Citation: W. Craig et al., Steering an appropriate course: principles to guide antibiotic choice - Discussion, RESP MED, 95, 2001, pp. S28-S29
The clinical impact of macrolide resistance in pneumococcal respiratory infections
Authors: Garau, J
Citation: J. Garau, The clinical impact of macrolide resistance in pneumococcal respiratory infections, INT J ANT A, 18, 2001, pp. S33-S38
Efficacy and safety of gemifloxacin in the treatment of community-acquiredpneumonia: a randomized, double-blind comparison with trovafloxacin
Authors: File, TM Schlemmer, B Garau, J Cupo, M Young, C
Citation: Tm. File et al., Efficacy and safety of gemifloxacin in the treatment of community-acquiredpneumonia: a randomized, double-blind comparison with trovafloxacin, J ANTIMICRO, 48(1), 2001, pp. 67-74
Pleural empyema due to Gemella morbillorum
Authors: Canet, JJ Hernandez, R Almagro, P Garau, J
Citation: Jj. Canet et al., Pleural empyema due to Gemella morbillorum, ENFERM INF, 19(4), 2001, pp. 189-189
Lung biopsy in pulmonary veno-occlusive disease
Authors: Almagro, P Alvarez, M Garau, J
Citation: P. Almagro et al., Lung biopsy in pulmonary veno-occlusive disease, CHEST, 120(4), 2001, pp. 1421-1421
Update on cross-resistance of fluoroquinolones
Authors: Garau, J
Citation: J. Garau, Update on cross-resistance of fluoroquinolones, INT J CL PR, 2000, pp. 94-98
Transesophageal echocardiography and antibiotic prophylaxis for infective endocarditis
Authors: Lacasa, JM Tost, J Saez, L Alvarez, A Garau, J
Citation: Jm. Lacasa et al., Transesophageal echocardiography and antibiotic prophylaxis for infective endocarditis, CL MICRO IN, 6(3), 2000, pp. 169-170
Mycoplasma hominis catheter-related infection in a patient with multiple trauma
Authors: Cuchi, E Cherta, I Garau, J
Citation: E. Cuchi et al., Mycoplasma hominis catheter-related infection in a patient with multiple trauma, CL MICRO IN, 6(2), 2000, pp. 115-116
Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis
Authors: File, T Schlemmer, B Garau, J Lode, H Lynch, S Young, C
Citation: T. File et al., Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis, J CHEMOTHER, 12(4), 2000, pp. 314-325
Bacteraemia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumours
Authors: Martino, R Gomez, L Pericas, R Salazar, R Sola, C Sierra, J Garau, J
Citation: R. Martino et al., Bacteraemia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumours, EUR J CL M, 19(4), 2000, pp. 320-323
Treatment of aspergilloma with intracavitary amphotericin-B
Authors: Lacasa, JM Marquez, M Morales, OS Ares, J Garau, J
Citation: Jm. Lacasa et al., Treatment of aspergilloma with intracavitary amphotericin-B, REV CLIN ES, 200(10), 2000, pp. 582-583
Influence of comorbidity and severity on the clinical outcome of bacteremic pneumococcal pneumonia treated with beta-lactam monotherapy
Authors: Garau, J Aguilar, L Rodriguez-Creixems, M Dal-Re, R Perez-Trallero, E Rodriguez, M Bouza, E
Citation: J. Garau et al., Influence of comorbidity and severity on the clinical outcome of bacteremic pneumococcal pneumonia treated with beta-lactam monotherapy, J CHEMOTHER, 11(4), 1999, pp. 266-272
Basing empiric treatment choices for respiratory tract infection on the results of the Alexander Project
Authors: Garau, J
Citation: J. Garau, Basing empiric treatment choices for respiratory tract infection on the results of the Alexander Project, J CHEMOTHER, 11, 1999, pp. 51-55
The role of glycopeptide antibiotics in the treatment of infective endocarditis
Authors: Gruneberg, RN Antunes, F Chambers, HF Garau, J Graninger, W Menichetti, F Peetermans, WE Pittet, D Shah, PM Vogelaers, D
Citation: Rn. Gruneberg et al., The role of glycopeptide antibiotics in the treatment of infective endocarditis, INT J ANT A, 12(3), 1999, pp. 191-198
Carbapenems in clinical practice: a guide to their use in serious infection
Authors: Bradley, JS Garau, J Lode, H Rolston, KVI Wilson, SE Quinn, JP
Citation: Js. Bradley et al., Carbapenems in clinical practice: a guide to their use in serious infection, INT J ANT A, 11(2), 1999, pp. 93-100
Emergence and dissemination of quinolone-resistant Escherichia coli in thecommunity
Authors: Garau, J Xercavins, M Rodriguez-Carballeira, M Gomez-Vera, JR Coll, I Vidal, D Llovet, T Ruiz-Bremon, A
Citation: J. Garau et al., Emergence and dissemination of quinolone-resistant Escherichia coli in thecommunity, ANTIM AG CH, 43(11), 1999, pp. 2736-2741
Risultati: 1-19 |